Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats

Drug Metabolism and Disposition

Volumn 27, Issue 6, 1999, Pages 689-694

  Song, Saeheum ^a   Suzuki, Hiroshi ^a   Kawai, Ryosei ^b   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIGOXIN; VALSPODAR; VINCRISTINE;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; DRUG ACTIVITY; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG TISSUE LEVEL; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; BILE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINS; DIGOXIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; P-GLYCOPROTEIN; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; VINCRISTINE;

ANIMALIA;

EID: 0033051587     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Belle SJ-PV, Smet DM, Neve WD, Monsaert C, Storme GA and Massart DL (1992) Determination of vinca alkaloids in mouse tissue by high-performance liquid chromatography. J Chromatogr 578:223-229.
2. Böhme M, Jedlitschky G, Leier I, Bilchler M and Keppler D (1994) ATP-dependent export pumps and their inhibition by cyclosporins. Adv Enzyme Regul 34:371-380.
3. Boote DJ, Dennis IF, Twentyman PR, Osborne RJ, Laburte C, Hensel S, Smyth JF, Brampton MH and Bleehen NM (1996) Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer. J Clin Oncol 14:610-618.
4. Charuk JH, Loo TW, Clarke DM and Reithmeier RA (1994) Interaction of rat kidney P-glycoprotein with a urinary component and various drugs including cyclosporin A. Am J Physiol 266:F66-F75.
5. Colombo T and Gonzalez PO (1996) Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia. Br J Cancer 73:866-871.
6. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR and Melamed MR (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38:1277-1287.
7. de Lannoy IA, Koren G, Klein J, Charuk J and Silvernan M (1992) Cyclosporin and quinidine inhibition of renal digoxin excretion: Evidence for luminal secretion of digoxin. Am J Physiol 263:F613-F622.
8. de Lannoy IA, Mandin RS and Silverman M (1994) Renal secretion of vinblastine, vincristine and colchicine in vivo. J Pharmacol Exp Ther 268:388-395.
9. Desrayaud S, De Lange ECM, Lemaire M, Bruelisauer A, De Boer AG and Breimer DD (1998) Effect of the Mdrla P-glycoprotein gene disruption on the tissue distribution of SDZ PSC 833, a multidrug resistance-reversing agent, in mice J Pharmacol Exp Ther 285:438-443.
10. Didier AD and Loor F (1996) Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors, lnt J Cancer 67:435-440.
11. Hori R, Okamura N, Aiba T and Tanigawara Y (1993) Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. J Pharmacol Exp Ther 266:1620-1625.
12. Ito S, Koren G, Harper PA and Silverman M (1993) Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PKI). Can J Physiol Pharmacol 71:40-47.
13. Jette L, Murphy GF, Leclerc JM and Beliveau R (1995) Interaction of drugs with P-glycoprotein in brain capillaries. Biochem Pharmacol 50:1701-1709.
14. Kamimoto Y, Gatmaitan Z, Hsu J and Arias IM (1989) The function of Gp170, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem 264:11693-11698.
15. Keller RP, Altermatt HJ, Nooter K, Poschmann G, Laissue JA. Bollinger P and Hiestand PC (1992) SDZ PSC 833, a non-immunosuppressive cyclosporin: Its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia. Int J Cancer 50:593-597.
16. Lemaire M, Bruelisauer A, Guntz P and Sato H (1996) Dose-dependent brain penetration of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin, in rats. Cancer Chemother Pharmacol 38:481-486.
17. Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, Halsey J and Sikic BI (1993) Clinical trials of modulation of multidrug resistance: Pharmacokinetic and pharmacodynamic considerations. Cancer 72(Suppl):3502-3514.
18. Mayer U, Wagenaar E, Beijnen JH, Smit JW, Meijer DK, van Asperen J, Borst P and Schinkel AH (1996) Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br J Pharmacol 119:1038-1044.
19. Miyamoto K, Wakusawa S and Nakamura S (1992) Drug resistance dependent on different molecular size P-glycoprotein in Yoshida rat ascites hepatoma cells. Biochem Pharmacol 43:1143-1145.
20. Ohnishi T, Tamai I. Sakanaka K, Sakata A, Yamashima T, Yamashita J and Tsuji A (1995) In vivo and in vitro evidence for ATP-dependency of P-glycoprotein-mediated efflux of doxorubicin at the blood-brain barrier. Biochem Pharmacol 49:1541-1544.
21. Pastan I and Gottesman MM (1987) Multi-drug resistance in human cancer. W Engl J Med 316:1388-1393.
22. Sakata A, Tamai I, Kawazu K, Deguchi Y, Ohnishi T, Saheki A and Tsuji A (1994) In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier. Biochem Pharmacol 48:1989-1992.
23. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJM, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE and Borst P ( 1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Nat Acad Sci USA 94:4028-4033.
24. Schinkel AH, Smit JJM, Telligen OV, Beijnen JH, Wagenaar E, Deemter LV, Mol CAAM, Valk MAVD, Robanus-Maandag EC, te Riele HPJ, Berns AJM and Borst P (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and increased sensitivity to drugs. Cell 77:491-502.
25. Schinkel AH, Wagenaar E, Deemter LV, Mol CAAM and Borst P (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin and cyclosporin A. J Clin Invest 96:1698-1705.
26. Simon N, Dailly E, Combes O, Malaurie E, Lemaire M, Tillement JP and Urien S (1998) Role of lipoproteins in the plasma binding of SDZ PSC 833, a novel multidrug resistance-reversing cyclosporin. Br J Clin Pharmacol 45:173-175.
27. Song SH, Suzuki H, Kawai R, Tanaka C, Akasaka I and Sugiyama Y (1998a) Dose-dependent effect of PSC 833 on its tissue distribution and on the biliary excretion of endogenous substrate in rats. Drug Metab Dispos 26:1128-1133.
28. Song SH, Suzuki H, Terasaki T, Lemaire M and Sugiyama Y (1998b) Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo. J Pharmacol Exp Ther 287:963-968.
29. Stone JA and Soldin SJ (1988) Improved liquid chromatographic/immunoassay of digoxin in serum. Clin Chem 34:2547-2551.
30. Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S and Mori S (1988) Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48:1926-1929.
31. Tamai I and Safa AR (1990) Competitive interaction of cyclosporins with the vinca alkaloid binding site of P-glycoprotein in multldrug-resistant cells. J Biol Chem 265:16509-16513.
32. Tellingen OV, Beijnen JH, Nooijen WJ and Bull A (1993) Tissue disposition, excretion and metabolism of vinblastine in mice as determined by high-performance liquid chromatography. Cancer Chemother Pharmacol 32:286-292.
33. Twentyman PR and Blechen NM (1991) Resistance modification by PSC-833, a novel nonimmunosuppressive cyclosporin. Eur J Cancer 27:1639-1642.
34. Watanabe T, Miyauchi S, Sawada Y, Iga T, Hanano M, Inaba M and Sugiyama Y (1992) Kinetic analysis of hepatobiliary transport of VCR in perfused rat liver. Possible roles of P-glycoprotein in biliary excretion of vincristine. J Hepatol 16:77-88.
35. Watanabe T, Suzuki H, Sawada Y, Naito M, Tsuruo T, Inaba M, Hanano M and Sugiyama Y (1995) Induction of hepatic P-glycoprotein enhances biliary excretion of vincristine in rats. J Hepatol 23:440-448.